More Govt Help For Korean Stem Cell, Gene Therapy Bioventures
This article was originally published in PharmAsia News
Executive Summary
The South Korean government has selected four stem cell and gene therapy firms to receive state funding over the next three years as part of its broad measures to foster world-class biotech companies and launch globally competitive biomedicines.